TY - JOUR
T1 - Imipenem-relebactam susceptibility testing of gram-negative bacilli by agar dilution, disk diffusion, and gradient strip methods compared with broth microdilution
AU - Hakvoort, Hanna
AU - Bovenkamp, Evelyn
AU - Greenwood-Quaintance, Kerryl E.
AU - Schmidt-Malan, Suzannah M.
AU - Mandrekar, Jay N.
AU - Schuetz, Audrey N.
AU - Patel, Robin
N1 - Publisher Copyright:
Copyright © 2020 American Society for Microbiology. All Rights Reserved.
PY - 2020/10
Y1 - 2020/10
N2 - This study aimed to determine whether agar dilution, research-use-only disk diffusion (Mast Group Ltd., Bootle Merseyside, UK), Etest (bioMérieux, Inc., Durham, NC), and MIC test strip (MTS) (Liofilchem, Inc., Waltham, MA) methods yield equivalent results to those of broth microdilution (BMD) for imipenem-relebactam susceptibility testing using a collection of 297 Gram-negative bacilli, including members of the order Enterobacterales and Pseudomonas aeruginosa, enriched for drug resistance. MIC and disk diameter results were interpreted using United States Food and Drug Administration breakpoints. Overall, 76.8% of the isolates tested were susceptible to imipenem-relebactam by BMD. MIC values for agar dilution, Etest, and MTS were not significantly different from that for BMD, although they tended to be 1 to 2 dilutions higher. Essential agreement was 95.6% for agar dilution, 90.6% for Etest, and 85.2% for MTS. Categorical agreement was 98.0% for agar dilution, 73.1% for disk diffusion, 96.3% for Etest, and 96.6% for MTS. In conclusion, agar dilution and Etest yielded comparable results to BMD for imipenem-relebactam.
AB - This study aimed to determine whether agar dilution, research-use-only disk diffusion (Mast Group Ltd., Bootle Merseyside, UK), Etest (bioMérieux, Inc., Durham, NC), and MIC test strip (MTS) (Liofilchem, Inc., Waltham, MA) methods yield equivalent results to those of broth microdilution (BMD) for imipenem-relebactam susceptibility testing using a collection of 297 Gram-negative bacilli, including members of the order Enterobacterales and Pseudomonas aeruginosa, enriched for drug resistance. MIC and disk diameter results were interpreted using United States Food and Drug Administration breakpoints. Overall, 76.8% of the isolates tested were susceptible to imipenem-relebactam by BMD. MIC values for agar dilution, Etest, and MTS were not significantly different from that for BMD, although they tended to be 1 to 2 dilutions higher. Essential agreement was 95.6% for agar dilution, 90.6% for Etest, and 85.2% for MTS. Categorical agreement was 98.0% for agar dilution, 73.1% for disk diffusion, 96.3% for Etest, and 96.6% for MTS. In conclusion, agar dilution and Etest yielded comparable results to BMD for imipenem-relebactam.
KW - Agar dilution
KW - Broth microdilution
KW - Disk diffusion
KW - Gradient strips
KW - Imipenem-relebactam
KW - Susceptibility testing
UR - http://www.scopus.com/inward/record.url?scp=85091565067&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85091565067&partnerID=8YFLogxK
U2 - 10.1128/JCM.00695-20
DO - 10.1128/JCM.00695-20
M3 - Article
C2 - 32727832
AN - SCOPUS:85091565067
SN - 0095-1137
VL - 58
JO - Journal of clinical microbiology
JF - Journal of clinical microbiology
IS - 10
M1 - e0069520
ER -